Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases.

Joachim Brumberg Ganna BlazhenetsSabrina BühlerJohannes FostitschMichel RijntjesYilong MaDavid EidelbergCornelius WeillerWolfgang H JostLars FringsNils SchroeterPhilipp T Meyer

Published in: Annals of neurology (2024)

F]fluorodeoxyglucose PET may improve the basis for therapy decisions, especially for invasive therapeutic procedures like deep brain stimulation in Parkinson's disease. ANN NEUROL 2024;96:539-550.

Keyphrases

deep brain stimulation
parkinson disease
positron emission tomography
pet ct
computed tomography
obsessive compulsive disorder
subarachnoid hemorrhage
pet imaging
free survival
neural network
stem cells
brain injury
cerebral ischemia
bone marrow
smoking cessation